Posts Tagged ‘Colorado State Board of Pharmacy’

Notice to All Licensed Colorado Pharmacists and Registered DEA Prescribing Practitioners

All Colorado licensed pharmacists and registered DEA prescribing practitioners are required to register an individual user account with Colorado’s Prescription Drug Monitoring Program (PDMP) pursuant to CRS 12-42.5-403 of the Pharmacy, Pharmacy Businesses and Pharmaceuticals Practice Act.  The following due dates for each profession are: Pharmacists and DEA-registered Advanced Practice Nurses:  September 30, 2014 DEA-registered…

Read More

Colorado State Board of Pharmacy Legislation Update No. 2

HB14-1083 – Acute Treatment Units Stock Medications HB14-1083 – Acute treatment units (ATU) provide medically supervised behavioral health treatment services to individuals who suffer from psychiatric disorders. Current law does not allow an ATU to have an onsite stock of medications. The bill allows an ATU to procure, store, order, dispense, and administer prescription medications and to…

Read More

Colorado State Board of Pharmacy Legislation Update: Modifications to the Electronic Prescription Drug Monitoring Program

HB14-1283 – Modify Prescription Drug Monitoring Program HB14-1283 makes the following modifications to the electronic prescription drug monitoring program: The dissemination of automatic reports to prescribers and pharmacies when a patient meets a defined threshold that takes into account the number of prescribers and pharmacies visited within a certain timeframe. Reports will start in September…

Read More

Compounding and Nonresident Pharmacies

In late 2012, an outbreak of fungal meningitis brought national attention to compounding pharmacies, the sterility and regulation of their compounded products, and the potential patient risks associated with compounded medications. At the heart of the outbreak was a medication called methylprednisolone acetate, a preservative free injectable steroid that was produced at the New England…

Read More